Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Comments on: Polymorphisms ind...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Bibliographic Details
Published in:Pharmacological Research
Main Authors: Paula Zapata-Cobo, Sara Salvador-Matín, Marta Velasco, Laura M. Palomino, Susana Clemente, Oscar Segarra, Ana Moreno-Álvarez, Ana Fernández-Lorenzo, Begoña Pérez-Moneo, Montse Montraveta, Cesar Sánchez, Mar Tolín, Inés Loverdos, María José Fobelo, Victor Manuel Navas-López, Lorena Magallares, Ruth García-Romero, José Germán Sánchez-Hernández, Alejandro Rodríguez, Ferrán Bossacoma, María Jesús Balboa, Enrique Salcedo, María Sanjurjo-Sáez, Luis A. López-Fernández
Format: Article
Language:English
Published: Elsevier 2023-10-01
Subjects:
Inflammatory bowel disease
Pharmacogenetics
Infliximab
Adalimumab
Polymorphism
Pediatric
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823002943
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1043661823002943

Similar Items

  • Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
    by: Sara Salvador-Martín, et al.
    Published: (2021-01-01)
  • Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
    by: Tatyana Valentinovna Mezenova, et al.
    Published: (2012-04-01)
  • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
    by: Yoon Suk Jung, et al.
    Published: (2021-01-01)
  • Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis
    by: Mario Gaio, et al.
    Published: (2024-07-01)
  • Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
    by: Stefania Cheli, et al.
    Published: (2023-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs